Literature DB >> 1330705

Salivary gland tumours: is colour Doppler imaging of added value in their preoperative assessment?

B A Ajayi1, N D Pugh, G Carolan, J P Woodcock.   

Abstract

Using a Toshiba SSA-270A Colour Duplex Scanner, 15 patients with suspected parotid and submandibular gland tumours had preoperative duplex scanning done. Peak systolic doppler shifts (fmax) were recorded and their vascularity was also subjectively scored. There were no arteries identified within the substance of contralateral normal glands. All recordings were analysed retrospectively and an independent histological assessment of tumours was made. Pleomorphic adenomas (n = 9) had a median peak systolic frequency (fmax) of 0.8 kHz, while adenolymphomas (n = 4) had a fmax of 1.65 and the two malignant tumours had fmax of 4.5 (P = 0.007 Kruskal-Wallis test). There appears to be a strong correlation between the fmax and the subjective vascular score (Corr 0.92). Colour duplex scanning is a non-invasive procedure which may be of help in the preoperative assessment of salivary gland tumours.

Entities:  

Mesh:

Year:  1992        PMID: 1330705

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

1.  Sonoelastography of parotid gland tumours: initial experience and identification of characteristic patterns.

Authors:  Nils Klintworth; Konstantinos Mantsopoulos; Johannes Zenk; Georgios Psychogios; Heinrich Iro; Alessandro Bozzato
Journal:  Eur Radiol       Date:  2012-01-22       Impact factor: 5.315

2.  A prospective study of three diagnostic sonographic methods in differentiation between benign and malignant salivary gland tumours.

Authors:  S M El-Khateeb; A E Abou-Khalaf; M M Farid; M A Nassef
Journal:  Dentomaxillofac Radiol       Date:  2011-12       Impact factor: 2.419

3.  Contrast-enhanced color Doppler sonography of parotid gland tumors.

Authors:  Helmut Steinhart; Johannes Zenk; Kirsten Sprang; Allessandro Bozzato; Heinrich Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-02-06       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.